Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Dosage Changes In Patients With Long-term Botulinum Toxin Use For Laryngeal Dystonia

H. Birkent, N. Maronian, P. Waugh, A. Merati, D. Perkel, A. Hillel
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
OBJECTIVE: To investigate the dosage consistency of botulinum toxin injections in patients with long-term treatment for laryngeal dystonia. STUDY DESIGN: Chart review. SUBJECTS AND METHODS: Patients with laryngeal dystonia who had received at least 20 injections to the thyroarytenoid muscle were selected. Change of botulinum toxin dose, patient-reported effective weeks, and intervals between injections were investigated; data from the first five injections were excluded to eliminate initial dose titration. RESULTS: Fifty-five patients with an average follow-up of 12.5 years were identified. Mean dose of botulinum toxin was 2.37 ± 1.6 U at the sixth injection; there was a decrease in mean dose over time, which became statistically significant at the 13th injection with a mean dose of 2.02 ± 1.16 U. Mean duration of good effect and treatment intervals showed no significant change over time. CONCLUSION: Botulinum toxin dose needed for a constant response in treatment of laryngeal dystonia decreases over time, without any accompanying change in effective weeks and intervals.
This paper references
Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia
C. Y. Chang (2007)
Long-Term Effects of Botulinum Toxin Injections in Spasmodic Dysphonia
B. Davidson (1996)
Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia
F. Gilio (2000)
Muscle Fiber-Type Changes Induced by Botulinum Toxin Injection in the Rat Larynx
K. Inagi (1999)
'Ping-pong' gaze
Borodic Ge (1992)
Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases. Laryngoscope 1988;98:636–40
A Blitzer (1988)
Effects of Botulinum Toxin on Pathophysiology in Spasmodic Dysphonia
S. Bielamowicz (2000)
Long-Distance Retrograde Effects of Botulinum Neurotoxin A
F. Antonucci (2008)
The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injection.
M. Byrnes (1998)
Botulinum Toxin: Basic Science and Clinical Uses in Otolaryngology
A. Blitzer (2001)
Acute and long-term effects of botulinum neurotoxin on the function and structure of developing extraocular muscles
Scott A. Croes (2007)
Repeated stimuli for axonal growth causes motoneuron death in adult rats: the effect of botulinum toxin followed by partial denervation
C. M. White (1999)
[Progression of botulinum toxin type A dosage in craniocervical dystonias. An eight year comparative study].
A. Echeverría Urabayen (2004)
The mechanism of action of Botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site
Nir Giladi (1997)
Part 2 : The study of laryngeal muscle activity in patients with laryngeal dystonia using multiple fine-wire electromyography
A. Hillel (2001)
Longitudinal assessment of the dose consistency of botulinum toxin type a (BOTOX®) for cervical dystonia
A. Brashear (2005)
Evolución de la dosis de toxina botulínica tipo A en distonías craneocervicales: Estudio comparativo a lo largo de ocho años
Amaya Echeverría Urabayen (2004)
Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias.
A. Blitzer (1986)
Long-Term Botulinum Toxin Dose Consistency for Treatment of Adductor Spasmodic Dysphonia
Paul K. Holden (2007)
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)
A. Blitzer (1988)
Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients—an Australian experience
S. Tisch (2003)
Pol - icy statement : botulinum toxin . Alexandria ( VA ) : American Academy of Otolaryngology – Head and Neck Surgery
A Blitzer (1997)
Effects of repeated botulinum toxin injections on orbicularis oculi muscle.
G. Borodic (1992)
Resistance to botulinum toxin injections for spasmodic dysphonia.
M. Smith (2000)
Clinical and laboratory characteristics of focal laryngeal dystonia: Study of 110 cases
Andrew Blitzer, Dds (1988)

This paper is referenced by
Spasmodic dysphonia: a seven-year audit of dose titration and demographics in the Indian population.
N. Nerurkar (2014)
Treatment for spasmodic dysphonia: limitations of current approaches
C. Ludlow (2009)
Botulinum Toxin Dosing Trends in Spasmodic Dysphonia Over a 20-year Period.
Arya W Namin (2017)
Botulinum Toxin-A Dosing Trends for Adductor Spasmodic Dysphonia at a Single Institution Over 10 Years.
J. P. Bradley (2017)
Botulinum Toxin in Pediatric Neurology : Switching Lanes From Death to Life
E. Moawad (2015)
Long-term Dose Stability of OnabotulinumtoxinA Injection for Adductor Spasmodic Dysphonia: A 19-Year Single Institution Experience
P. Paddle (2017)
Factors influencing long-term treatment response to botulinum toxin injection for spasmodic dysphonia.
Min Seong Kang (2020)
Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues.
D. Young (2014)
Current and future medical treatment in primary dystonia
C. Delnooz (2012)
Botulinum Toxin in Pediatric Neurology
E. Moawad (2015)
Avaliação vocal e da qualidade de vida em pacientes com distonia laríngea em tratamento com toxina botulínica
G. V. E. Rojas (2013)
Alternating Unilateral Versus Bilateral Injections of Botulinum Toxin for the Treatment of Adductor Spasmodic Dysphonia.
Seung Goo Lee (2020)
Tratamento médico e fonoaudiológico da disfonia espasmódica: uma revisão bibliográfica
E. Fabron (2013)
OnabotulinumtoxinA for adductor spasmodic dysphonia (ADSD): Functional results and the role of dosage.
M. R. Marchese (2018)
Factors influencing botulinum toxin dose instability in spasmodic dysphonia patients.
D. Rosow (2015)
Voice disorders in the workplace: Productivity in spasmodic dysphonia and the impact of botulinum toxin
T. Meyer (2013)
Influence of age and gender on dose and effectiveness of botulinum toxin for laryngeal dystonia
S. Vasconcelos (2009)
Semantic Scholar Logo Some data provided by SemanticScholar